Publication | Open Access

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial

Hematological MalignancyLymphoid NeoplasiaZanubrutinib Versus BendamustineMedicineHematologyPathologyPharmacotherapyCancer TreatmentSmall Lymphocytic LymphomaOncologyRadiation OncologyPhase 3Health Sciences